GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

MEDGENICS INC. (MDGN) President and CEO Andrew Pearlman sells 11,000 Shares

September 19, 2012 | About:
insider

insider

57 followers
President and CEO of MEDGENICS INC. (MDGN) Andrew Pearlman sells 11,000 shares of MDGN on 09/18/2012 at an average price of $10.27 a share.

Medgenics Inc has a market cap of $136.6 million; its shares were traded at around $11.11 .


This is the insider trade history vs. stock price of MDGN. For the complete insider trading history of MDGN, click here.




Directors and Officers Recent Trades:



  • COO Clarence L Dellio sold 3,007 shares of MDGN stock on 09/14/2012 at the average price of 10.74. The price of the stock has increased by 3.45% since.
  • Director Joel S Kanter sold 700 shares of MDGN stock on 08/30/2012 at the average price of 13.03. Joel S Kanter owns at least 214,068 shares after this. The price of the stock has decreased by 14.74% since.
  • Director Stephen D Mcmurray sold 10,935 shares of MDGN stock on 08/24/2012 at the average price of 12.5. Stephen D Mcmurray owns at least 79,835 shares after this. The price of the stock has decreased by 11.12% since.


For the complete insider trading history of MDGN, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 4.0/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK